Following Mercia‘s recent life sciences portfolio, three of Mercia’s portfolio CEOs talk about their businesses with Edison: John Burt, CEO of Medherant; John von Benecke, CEO of Locate Bio; and Dr Harry Lamble, CEO of Sense Biodetection. They discuss the support they have received as part of the Mercia family, how their businesses have progressed, how COVID-19 has accelerated change across the sector and also touch on the likely drivers of future growth.
Proactive specialist asset management
We provide venture, private equity or debt finance to regional businesses with growth ambition.
